Verified email at
Cited by
Cited by
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European …
Ž Reiner, AL Catapano, G De Backer, I Graham, MR Taskinen, O Wiklund, ...
European heart journal 32 (14), 1769-1818, 2011
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of …
BG Nordestgaard, MJ Chapman, SE Humphries, HN Ginsberg, L Masana, ...
European heart journal 34 (45), 3478-3490, 2013
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of …
F Mach, C Baigent, AL Catapano, KC Koskinas, M Casula, L Badimon, ...
European heart journal 41 (1), 111-188, 2020
Lipoprotein (a) as a cardiovascular risk factor: current status
BG Nordestgaard, MJ Chapman, K Ray, J Borén, F Andreotti, GF Watts, ...
European heart journal 31 (23), 2844-2853, 2010
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European …
BA Ference, HN Ginsberg, I Graham, KK Ray, CJ Packard, E Bruckert, ...
European heart journal 38 (32), 2459-2472, 2017
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
MJ Chapman, HN Ginsberg, P Amarenco, F Andreotti, J Borén, ...
European heart journal 32 (11), 1345-1361, 2011
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society consensus panel statement on assessment, aetiology and management
ES Stroes, PD Thompson, A Corsini, GD Vladutiu, FJ Raal, KK Ray, ...
European heart journal 36 (17), 1012-1022, 2015
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European …
AL Catapano, Ž Reiner, G De Backer, I Graham, MR Taskinen, O Wiklund, ...
Atherosclerosis 217, 1-44, 2011
Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis
PJ Barter, HB Brewer Jr, MJ Chapman, CH Hennekens, DJ Rader, ...
Arteriosclerosis, thrombosis, and vascular biology 23 (2), 160-167, 2003
Effect of two intensive statin regimens on progression of coronary disease
SJ Nicholls, CM Ballantyne, PJ Barter, MJ Chapman, RM Erbel, P Libby, ...
New England Journal of Medicine 365 (22), 2078-2087, 2011
Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis
A Kontush, MJ Chapman
Pharmacological reviews 58 (3), 342-374, 2006
Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets
G Barba, F Harper, T Harada, M Kohara, S Goulinet, Y Matsuura, G Eder, ...
Proceedings of the National Academy of Sciences 94 (4), 1200-1205, 1997
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia
JC Fruchart, F Sacks, MP Hermans, G Assmann, WV Brown, R Ceska, ...
The American journal of cardiology 102 (10), 1K-34K, 2008
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on …
M Cuchel, E Bruckert, HN Ginsberg, FJ Raal, RD Santos, RA Hegele, ...
European heart journal 35 (32), 2146-2157, 2014
Animal lipoproteins: chemistry, structure, and comparative aspects
MJ Chapman
Journal of lipid research, 1980
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel
PJ Barter, CM Ballantyne, R Carmena, MC Cabezas, MJ Chapman, ...
Journal of internal medicine 259 (3), 247-258, 2006
A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum.
MJ Chapman, S Goldstein, D Lagrange, PM Laplaud
Journal of lipid research 22 (2), 339-358, 1981
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
A Wiegman, SS Gidding, GF Watts, MJ Chapman, HN Ginsberg, M Cuchel, ...
European heart journal 36 (36), 2425-2437, 2015
Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity
B Hansel, P Giral, E Nobecourt, S Chantepie, E Bruckert, MJ Chapman, ...
The Journal of Clinical Endocrinology & Metabolism 89 (10), 4963-4971, 2004
HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events
RS Rosenson, HB Brewer Jr, MJ Chapman, S Fazio, MM Hussain, ...
Clinical chemistry 57 (3), 392-410, 2011
The system can't perform the operation now. Try again later.
Articles 1–20